Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
Akshay Kapoor, Eileen Crowley
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 15

Showing 15 citing articles:

Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?
Bram Verstockt, Brian Bressler, Helena Martínez-Lozano, et al.
Gastroenterology (2022) Vol. 162, Iss. 5, pp. 1370-1382
Closed Access | Times Cited: 41
Pediatric Inflammatory Bowel Disease
Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen
PEDIATRICS (2022) Vol. 151, Iss. 1
Open Access | Times Cited: 41
Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center
Roxana Elena Matran, Andra-Mihaela Diaconu, Andreea Maria Iordache, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 84-84
Open Access
Laboratory Tests in Inflammatory Bowel Disease: An Evidence-Based Approach to Daily Practice
Katelin Durham, Tyler Atagozli, David E. Elliott, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 491-491
Open Access
Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases
Anna Kofla-Dłubacz, Katarzyna Akutko, Elżbieta Krzesiek, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 994-994
Open Access | Times Cited: 7
Ustekinumab trough levels in children with Crohn’s disease refractory to anti-tumor necrosis factor agents: a prospective case series of off-label use
Marleen Bouhuys, Paola Mian, Patrick F. van Rheenen
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study
Susana Clemente, Óscar Segarra Cantón, Núria Padullés Zamora, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1577-1577
Open Access
Monitoramento terapêutico de Infliximabe na doença de Crohn
Luís Eduardo Miani Gomes
(2024)
Closed Access
Monitoreo de los niveles séricos de Infliximab y anticuerpos anti-infliximab en pacientes pediátricos con enfermedad inflamatoria intestinal: experiencia en un hospital pediátrico de alta complejidad de Buenos Aires, Argentina
Eugenia Micheletti, Cristina Eichhorn, Mariela Andrea Antoniska, et al.
Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana (2024) Vol. 54, Iss. 2, pp. 141-146
Open Access
Proactive monitoring of anti-TNF agents improves follow-up of paediatric patients with Crohn disease
Begoña Rodríguez Azor, Rafael Martín‐Masot, Anita Dayaldasani Khialani, et al.
Anales de Pediatría (English Edition) (2023) Vol. 98, Iss. 3, pp. 165-174
Open Access | Times Cited: 1
Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
Brindusa Truta
World Journal of Gastroenterology (2022) Vol. 28, Iss. 13, pp. 1380-1383
Open Access | Times Cited: 2
La monitorización proactiva de niveles de anti-TNF mejora el seguimiento de los pacientes pediátricos con enfermedad de Crohn
Begoña Rodríguez Azor, Rafael Martín‐Masot, Anita Dayaldasani Khialani, et al.
Anales de Pediatría (2022) Vol. 98, Iss. 3, pp. 165-174
Open Access | Times Cited: 2
The use of drug monitoring of infliximab and adalimumab to optimize the treatment of inflammatory bowel diseases in children
Т. В. Радыгина, A Illarionov, С. В. Петричук, et al.
Russian Pediatric Journal (2022) Vol. 25, Iss. 5, pp. 313-320
Open Access | Times Cited: 2
Trough Concentration Response in Infliximab and Adalimumab Treated Children With Inflammatory Bowel Disease Following Treatment Adjustment: A Pharmacokinetic Model
Rachel Levy, Manar Matar, Maya Zvuloni, et al.
Journal of Pediatric Gastroenterology and Nutrition (2023) Vol. 76, Iss. 5, pp. 576-581
Closed Access
Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease
Silvana Ancona, Sara Signa, Chiara Longo, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 38, pp. 5428-5434
Open Access
Page 1

Scroll to top